Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Clinical Pharmacy and Therapeutics|November 9, 2019
ANRIL and atherosclerosisLi Chen, Hua Qu, Ming Guo, et al.
Frontiers in Cardiovascular Medicine|May 14, 2025
A multi-center, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of Fuzheng Yangxin Granule in treating heart failure with preserved ejection fraction (Qi-Yin deficiency and blood stasis syndrome): study protocolJingjing Chen, Zian Yan, Jiacong Wang, et al.
Trials|April 17, 2019
Songling Xuemaikang capsules for patients with low-to-medium risk hypertension: study protocol for a randomized controlled trialYuerong Jiang, Haiyan Guo, Yue Liu, et al.
Frontiers in Cardiovascular Medicine|May 22, 2026
Correction: A multi-center, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of Fuzheng Yangxin Granule in treating heart failure with preserved ejection fraction (Qi-Yin deficiency and blood stasis syndrome): study protocolJingjing Chen, Zian Yan, Jiacong Wang, et al.
Biomedicines|November 27, 2025
The Bidirectional Relationship Between Myocardial Infarction and Depression: Risk Factors, Mechanisms, and InterventionsZhuorui Cui, Qiaoning Yang, Furong Yang, et al.
Frontiers in Psychiatry|June 21, 2024
Genetic analyses of the bidirectional associations between common mental disorders and asthmaZian Yan, Jingjing Chen, Lijun Guo, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|July 23, 2025
Xinyue capsule treatment on long-term outcomes in patients with stable coronary artery disease after PCI: A 10-year observational follow-upMing Guo, Pengfei Chen, Jianpeng Du, et al.
Trials|September 14, 2021
The novel effectiveness of Tai Chi on cardiopulmonary fitness among stroke patients in the recovery phase: a study protocol for a randomized controlled trialTianyang Tan, Yanyan Meng, Xinyu Li, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|October 17, 2024
Qingxin Jieyu Granule alleviates myocardial infarction through inhibiting neutrophil extracellular traps via activating ANXA1/FPR2 axisMingzhu Qi, Helan Huang, Zhuohang Li, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|January 7, 2023
The effectiveness and safety of Chinese Patent Medicines based on syndrome differentiation in patients following percutaneous coronary intervention due to acute coronary syndrome (CPM trial): A nationwide Cohort StudyRuina Bai, Qiaoning Yang, Ruixi Xi, et al.
Pageof 3